Author:
Kamel A M,El-Sharkawy N,Mahmoud H K,Khalaf M-R,Haddad A El,Fahmy O,Fattah R Abd El,Sayed D
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference51 articles.
1. Andrews RG, Briddell RA, Hill R et al. Engraftment of primates with G-CSF mobilized peripheral blood CD34+ progenitor cells expanded in G-CSF, SCF, MGDF decreases the duration and severity of neutropenia. Stem Cells 1999; 17: 210–218.
2. Siena S, Schavo R, Pedrazzoli P, Carlo-Stella C . Therapeutic relevance of CD34 cell dose and blood cell transplantation for cancer therapy. J Clin Oncol 2000; 18: 1360–1377.
3. Zaucha JM, Gooley T, Bensinger WI et al. CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear allografts affects engraftment kinetics and development of extensive chronic graft versus host disease after human leukocyte antigen-identical sibling transplantation. Blood 2001; 98: 3221–3227.
4. Belvedere O, Feruglio C, Malangone W et al. Increased blood volume and CD34+/CD38− progenitor cell recovery using a novel umbilical cord blood collection system. Stem Cells 2000; 18: 245–251.
5. Cutler C, Giri S, Jeyapalan S . Incidence of acute and chronic graft versus host disease after allogeneic peripheral blood stem cell and bone marrow transplantation: a meta-analysis. Blood 2000; 96: 205a (Abstract).
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献